China’s National Medical Products Administration (NMPA) has approved pimicotinib (ABSK021) as a treatment for adults with symptomatic tenosynovial giant cell tumors (TGCTs) for which surgery may cause functional limitation or relatively severe morbidity, …

… Pharmaceuticals CASI Pharmaceuticals, Inc. is a public biopharmaceutical company … business strategy on a global basis including China; … products (such as marketing, safety, regulatory, patent … Company's earlier SEC filing for further information. INVESTOR …

… investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals … settlement against a Chinese Company. Rosen Law Firm … statements about Telix’s business, operations, and prospects … the market, the lawsuit claims that investors suffered …

… Shanghai on July 29. CHEN YUYU/FOR CHINA DAILY Chinese … president of the company's health business unit, said the … , diagnosis, payment and pharmaceutical delivery and create a user- … , and foster cross-industry collaboration." Baidu Inc recently …

… per cent stake in its China-based joint venture for USD … the company, has entered into a binding agreement with Shandong Luoxin Pharmaceutical … a 30:70 joint venture company between Helix and Shandong Luoxin …

… Shanghai Innovation Bank, and leading venture capital firms … market … Investment” brought together experts from venture capital, banking, and pharmaceutical … Investment Judging Panel, composed of seasoned investors and industry leaders, focused on business …

Abbisko Therapeutics Co. Ltd. and its partner Merck KGaA got an early Christmas present from China’s National Medical Products Administration (NMPA) with the approval of pimicotinib (ABSK-021), the first domestically developed systemic therapy for …

A New Drug Application for Cobenfy (xanomeline-trospium) has been approved by China’s National Medical Products Administration (NMPA), Zai Labs announced today.1 The NMPA approved the medication for treatment of schizophrenia in adults. The approval was …

… to the Illegal Medication Market," health authorities blamed … the MINSAP, the national pharmaceutical industry has lost production capacity … with countries like India, China, and Spain, and … The prolonged health and pharmaceutical crisis affecting Cuba …

… China, India, Japan, Australia, and additional markets … validated foundation for investment, portfolio expansion, … companies and pharmaceutical firms for drug … INDUSTRY KEYWORD: GENETICS HEALTH MEDICAL DEVICES SOURCE: Research and Markets Copyright Business …